Delivery Order SPE2DB22D9319-SPE2DB24FK2NE

Award Date 8/5/24
Potential Completion Date 8/26/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $13,024.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg intrauterine systems, a contraceptive product. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDV) SPE2DB with DLA, valued at up to $4,999,999 through 2025, which...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract has a ceiling value of $1,726.89 and is a firm fixed-price delivery order with no set-aside designation. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This award is part of a larger indefinite delivery contract (IDC) held by DMS...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth up to $1,184.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,564,029,380 units of Mirena 52 mg contraceptive intrauterine systems. The delivery order has an ultimate completion date of April 8, 2024 and was awarded on March 18, 2024. This contract is part of DMS Pharmaceutical Group's existing indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the delivery of 4,562,293,327 units of Mirena 52 mg systems. The award, valued at $29,048.00, has an ultimate completion date of October 11, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $12,432.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg systems, a type of contraceptive implant. This delivery order is part of a larger indefinite delivery, indefinite quantity (IDIQ) contract, number SPE2DB24FY22J, held by DMS Pharmaceutical Group with DLA. The IDIQ contract, valued at up to...
This federal contract award, with ID SPE2DB22D9124|SPE2DB25FP4HE, was issued by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for 4,566,289,121 units of the Mirena 52 mg contraceptive system, with a firm fixed price of $5,920.00 and a completion date of November 20, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $7,811.55 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the procurement of 4,567,759,894 units of the Mirena 52 mg contraceptive system. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a wide range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $4,736.00, is for the delivery of Mirena 52 mg intrauterine systems, a contraceptive device. The contract is a firm fixed-price delivery order under a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which runs through December 31, 2025. This IDC...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,564,414,792 units of the Mirena 52 mg intrauterine contraceptive system. The contract has a ceiling value of $11,840.00 and an ultimate completion date of May 15, 2024. This delivery order was issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (SPE2DB) with the DLA's Medical Supply Chain...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at up to $14,208, is for the delivery of Mirena 52 mg intrauterine contraceptive systems. It is a firm fixed-price delivery order contract with an ultimate completion date of April 17, 2024. The contract is not associated with any set-aside program. It is part of a larger indefinite delivery/indefinite quantity...
  • SPE2DB22D9319
    Indefinite Delivery Contract
  • SPE2DB22D9319-SPE2DB24FK2NE
    Delivery Order

This federal contract award is for the delivery of 4,565,404,982 units of the Mirena 52 mg intrauterine system to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $4,736.00, is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois.

DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 11/4/24, 10:30 AM